welbournes

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Aqueous cream 100 £1.11 Clarithromycin 125mg/5ml oral suspension 70 £4.72 Clotrimazole 500mg [...]

The post October 2024 Price Concessions – 3rd Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Drug alert number: EL (24)A/51 Date issued: 28 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Company name: Kent Pharma UK Product [...]

The post MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 3 October 2024) has been published and includes articles on: GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse. Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on [...]

The post MHRA: Drug Safety Update: October 2024 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Agomelatine 25mg tablets 28 £13.50 Amitriptyline 50mg/5ml oral solution sugar free 150 [...]

The post October 2024 Price Concessions – 2nd Update appeared first on Community Pharmacy England.

National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup National Patient Safety Alert Reference Number: NatPSA/2024/011/DHSC Date issued: 21-Oct-2024 This NatPSA supersedes NatPSA/2024/008/DHSC This alert is for action by: All organisations involved in prescribing, dispensing and administering Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup. This is a safety critical [...]

The post National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup appeared first on Community Pharmacy England.